Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

P2Y12 inhibitor; monotherapy; percutaneous coronary intervention; dual antiplatelet therapy; high bleeding risk; high on-treatment platelet reactivity; randomized controlled trial; left atrial appendage thrombus; atrial fibrillation; stroke; oral anticoagulant; cardiovascular diseases; novel antithrombotic agents; antiplatelet drugs; anticoagulants; hemostasis; factor XI; factor XI inhibitor; thrombosis; new drugs; left ventricular thrombus; anticoagulation; anterior wall myocardial infarction; dual therapy; direct oral anticoagulants; surface plasmon resonance; metformin; matrix metalloproteinase-9; plaque instability; atherosclerosis; cancer; acute coronary syndrome (ACS); percutaneous coronary intervention (PCI); dual antiplatelet therapy (DAPT); triple antithrombotic therapy (TAT); atrial fibrillation (AF); cardiotoxicity; aspirin; coronary artery disease; cerebrovascular disease; diabetes mellitus; essential thrombocythemia; platelet function; thromboxane; gastrointestinal bleeding; enteric-coated aspirin; cardiovascular prevention; P2Y12 inhibitors; acute coronary syndrome; clopidogrel; prasugrel; ticagrelor; cangrelor; selatogrel; zalunfiban; peripheral artery disease (PAD); antithrombotic therapy; dual pathway inhibition (DPI); major adverse cardiovascular events (MACE); major adverse limb events (MALE); n/a